MINS Study

  • Dr
    Justin Nazareth

Project Details

MINS Study: Myocardial injury after noncardiac surgery sub-study of the VAPOR-C Trial

Hypothesis and aims

We hypothesise that the use of intraoperative intravenous lidocaine infusion during major surgery will reduce the incidence of MINS compared to placebo.

Primary aim:
1) To compare the incidence of MINS with the use of intraoperative intravenous lidocaine to placebo.

Endpoint definition: MINS will be defined as a Troponin level (Troponin I or Troponin T) greater than the 99th percentile of the upper reference limit, in accordance with the Fourth Universal Definition of Myocardial Infarction [24].

Secondary aim:
1) To measure the association between perioperative inflammatory changes, troponin rise, MINS and postoperative outcomes.

Endpoints: length of stay (days); postoperative complications and mortality at 30 days and 1 year. Perioperative inflammatory change will be measured by perioperative change in C-Reactive Protein (CRP), neutrophil-lymphocyte ratio (NLR) and inflammatory cytokines.

Study population

Participants recruited to the VAPOR-C Trial will be eligible for inclusion in the MINS Study and approached for recruitment.


Chief Investigators

Dr Justin Nazareth
Dr Tim Coulson
Dr Julia Dubowitz
Professor Bernhard Riedel

Associate Investigators

Dr Mark Nolan
Professor Philip Peyton
Professor P J Devereaux


Australian and New Zealand College of Anaesthetists

Research Group

Anaesthesia, Perioperative and Pain Medicine

School Research Themes

Critical Care

Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Critical Care

MDHS Research library
Explore by researcher, school, project or topic.